Business Description
Fujian Aonong Biological Technology Group Incorp Ltd
ISIN : CNE100002VK6
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.06 | |||||
Debt-to-Equity | 8.12 | |||||
Debt-to-EBITDA | -5.57 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.3 | |||||
Beneish M-Score | -3.35 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 41.1 | |||||
3-Year EBITDA Growth Rate | 5.1 | |||||
3-Year FCF Growth Rate | -33.5 | |||||
3-Year Book Growth Rate | 25.1 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.12 | |||||
9-Day RSI | 34.07 | |||||
14-Day RSI | 37.58 | |||||
6-1 Month Momentum % | -28.84 | |||||
12-1 Month Momentum % | -42.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.36 | |||||
Quick Ratio | 0.14 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 52.22 | |||||
Days Sales Outstanding | 11.12 | |||||
Days Payable | 68.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.6 | |||||
Shareholder Yield % | 17.74 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 0.51 | |||||
Operating Margin % | -4.85 | |||||
Net Margin % | -8.21 | |||||
FCF Margin % | 2.63 | |||||
ROE % | -85.31 | |||||
ROA % | -9.79 | |||||
ROIC % | -5.32 | |||||
ROC (Joel Greenblatt) % | -16.01 | |||||
ROCE % | -24.53 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.15 | |||||
PB Ratio | 2.98 | |||||
Price-to-Tangible-Book | 364 | |||||
Price-to-Free-Cash-Flow | 5.48 | |||||
Price-to-Operating-Cash-Flow | 2.37 | |||||
EV-to-EBIT | -7.42 | |||||
EV-to-EBITDA | -7.42 | |||||
EV-to-Revenue | 0.54 | |||||
EV-to-FCF | 20.45 | |||||
Earnings Yield (Greenblatt) % | -13.48 | |||||
FCF Yield % | 17.77 |